NCT05427448View on ClinicalTrials.gov

Validation of Blood Biomarkers for Alzheimer's Disease

NARecruitingINTERVENTIONAL
Enrollment

342

Participants

Timeline

Start Date

November 24, 2022

Primary Completion Date

November 24, 2024

Study Completion Date

December 31, 2024

Conditions
Alzheimer DiseaseMild Cognitive ImpairmentDementiaTauopathies
Interventions
DIAGNOSTIC_TEST

Measurement of amyloid and pTau blood biomarkers

Detection of plasma Amyloid beta 1-40 and 1-42 peptide and phosphorylated tau isoforms.

Trial Locations (3)

30000

RECRUITING

Nîmes University Hospital, Nîmes

34000

RECRUITING

Montpellier University Hospital, Montpellier

66000

RECRUITING

Perpignan Regional Hospital, Perpignan

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER